Sufficient scientific evidence exists to recommend HPV DNA testing in the triage of women with equivocal cytology and in follow-up after the treatment of precursor lesions. However, due to a low ...

The virus, known as HPV, can trigger cancers, including those in the head, neck and cervix. While the highly effective vaccine has been offered to all girls in Year 8 since 2008, and all boys ...

Opens in a new tab or window Surgical innovations for breast cancer have led to personalized treatment choices that are more complex than lumpectomy versus mastectomy. (Mayo Clinic) Using a breast ...

patients who test positive for HPV will still need to come back for an appointment with their practitioner — to go over treatment options and receive a clinician swab for further testing.

Daré Bioscience has secured a $10 million milestone-based funding from the ARPA-H Sprint for Women’s Health to advance DARE-HPV, an innovative treatment for HPV-related cervical diseases.

The funding, to be received over two years, will support the development of DARE-HPV, Dare Bioscience's investigational treatment for human papillomavirus (HPV)-related cervical disease.

The funding, to be received over two years, will support the development of DARE-HPV, Dare Bioscience's investigational treatment for human papillomavirus (HPV)-related cervical disease. HPV is a ...

国家卫生健康委10月18日举行新闻发布会，介绍推动加速消除宫颈癌有关情况。发布会上，专家介绍，HPV疫苗能够阻断高危型HPV的持续感染，从而有效降低宫颈癌及癌前病变的发生率。但是目前的HPV疫苗是预防性疫苗，没有治疗作用，疫苗也不包含所有可以导致 ...